| Primary |
| Drug Use For Unknown Indication |
100.0% |
|
| Gastrooesophageal Reflux Disease |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
28.0% |
| Cardiac Disorder |
8.0% |
| Completed Suicide |
8.0% |
| Asthma |
6.7% |
| Drug Use For Unknown Indication |
6.7% |
| Anaemia |
5.3% |
| Cough |
5.3% |
| Lower Respiratory Tract Infection |
4.0% |
| Blood Test Abnormal |
2.7% |
| Constipation |
2.7% |
| Convulsion |
2.7% |
| Depression |
2.7% |
| Empyema |
2.7% |
| Iron Deficiency Anaemia |
2.7% |
| Mycobacterium Abscessus Infection |
2.7% |
| Schizophrenia |
2.7% |
| Supplementation Therapy |
2.7% |
| Anxiety |
1.3% |
| Epilepsy |
1.3% |
| Gastrointestinal Disorder Therapy |
1.3% |
|
| Treatment Failure |
14.3% |
| Premature Baby |
9.5% |
| Stevens-johnson Syndrome |
9.5% |
| Completed Suicide |
4.8% |
| Gastritis |
4.8% |
| Nausea |
4.8% |
| Neonatal Respiratory Distress Syndrome |
4.8% |
| Neuroleptic Malignant Syndrome |
4.8% |
| Product Quality Issue |
4.8% |
| Productive Cough |
4.8% |
| Selenium Deficiency |
4.8% |
| Toxic Skin Eruption |
4.8% |
| Type 2 Diabetes Mellitus |
4.8% |
| Uterine Hypotonus |
4.8% |
| Weight Decreased |
4.8% |
| Withdrawal Syndrome |
4.8% |
| X-ray Abnormal |
4.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
51.7% |
| Drug Use For Unknown Indication |
5.8% |
| Rheumatoid Arthritis |
4.1% |
| Anaemia |
4.1% |
| Pain |
4.0% |
| Hypertension |
3.9% |
| Crohn's Disease |
2.9% |
| Nausea |
2.8% |
| Asthma |
2.1% |
| Anxiety |
2.0% |
| Atrial Fibrillation |
2.0% |
| Convulsion |
2.0% |
| Depression |
2.0% |
| Hepatitis C |
1.8% |
| Infection |
1.8% |
| Prophylaxis |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| B-cell Lymphoma |
1.3% |
| Diabetes Mellitus |
1.3% |
| Epilepsy |
1.3% |
|
| Weight Decreased |
11.7% |
| Vomiting |
10.9% |
| Thrombocytopenia |
7.3% |
| Urinary Tract Infection |
6.6% |
| Pneumonia |
5.8% |
| Swelling Face |
5.8% |
| Weight Increased |
5.1% |
| Pulmonary Embolism |
4.4% |
| Syncope |
4.4% |
| Unresponsive To Stimuli |
4.4% |
| Pain |
3.6% |
| Pulmonary Fibrosis |
3.6% |
| Respiratory Failure |
3.6% |
| Tetany |
3.6% |
| Thrombosis |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Fall |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Loss Of Consciousness |
2.9% |
| Melaena |
2.9% |
|
| Interacting |
| Lower Respiratory Tract Infection |
50.0% |
| Product Used For Unknown Indication |
50.0% |
|
|
